AN ACT REQUIRING NEWBORN SCREENING FOR DUCHENNE MUSCULAR DYSTROPHY.
Connecticut requires hospitals to screen all newborns for Duchenne muscular dystrophy to enable early medical intervention and family planning.
Connecticut requires hospitals to screen all newborns for Duchenne muscular dystrophy to enable early medical intervention and family planning.
HB 5710 mandates that Connecticut include Duchenne muscular dystrophy (DMD) screening in its newborn screening program. This genetic disorder causes progressive muscle weakness and typically manifests in early childhood. The bill requires the state to identify affected infants shortly after birth through standardized screening protocols.
Early detection of DMD allows families to begin medical interventions—including physical therapy, medications, and monitoring—that can significantly improve quality of life and slow disease progression. Newborns identified through screening can receive counseling, genetic testing confirmation, and access to emerging treatments like gene therapy before symptoms appear. Currently, DMD is often diagnosed only after symptoms become apparent, potentially delaying critical care by months or years.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.